Preparation method of melatonin copper-silver composite nanoparticles and their application against Ralstonia solanacearum

By preparing melatonin copper-silver composite nanoparticles, the problems of pathogen resistance and material stability in the control of bacterial wilt were solved, realizing the stable application and comprehensive control effect of nanomaterials in agriculture.

CN123100661APending Publication Date: 2026-11-17XICHANG COLLEGE
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202611363202.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-04
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing methods for controlling bacterial wilt have problems such as pathogen resistance, soil residues, low control efficiency, limited functionality of nanomaterials, and unstable binding of melatonin with metal nanomaterials, making it difficult to achieve green and efficient integrated control.

Method used

Using bovine serum albumin as a template and sodium borohydride as a reducing agent, melatonin copper-silver composite nanoparticles were prepared by room temperature aqueous phase method. Combined with in-situ modification of melatonin, a stable composite structure was formed, which has dual antibacterial and antioxidant activities.

Benefits of technology

It enables the stable application of nanomaterials in complex environments, possesses both antibacterial and antioxidant functions, enhances the overall control effect of bacterial wilt, and is suitable for promotion in agricultural scenarios.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100661A_ABST
    Figure CN123100661A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of nano-antibacterial materials technology, and provides a method for preparing melatonin copper-silver composite nanoparticles and their application against Ralstonia solanacearum. The method for preparing the melatonin copper-silver composite nanoparticles includes the following steps: dissolving bovine serum albumin in sterile water at room temperature; adding copper sulfate solution and mixing at room temperature to obtain a first mixed solution; adding silver nitrate solution and sterile water to the first mixed solution and mixing in the dark to obtain a second mixed solution. This invention features a wide range of adjustable process parameters, operates entirely at room temperature, and is easy to use. The prepared material exhibits both in vitro free radical scavenging activity and Ralstonia solanacearum inhibitory activity. The bimetallic component and the melatonin modification layer can work synergistically, showing stable antibacterial effects against multiple strains of Ralstonia solanacearum, providing a novel nanomaterial alternative for the green control of bacterial wilt.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of nano-antibacterial materials technology, and particularly relates to the preparation method of melatonin copper-silver composite nanoparticles and their application against Ralstonia solanacearum. Background Technology

[0002] Bacterial wilt, caused by Ralstonia solanacearum, is a devastating soil-borne bacterial disease. This pathogen has a wide host range, infecting over 450 species of economic crops from 54 families, including tomatoes, potatoes, eggplants, peppers, and tobacco. After infection, it causes rapid wilting of host plants, leading to significant yield losses in severe cases, making it one of the most serious bacterial diseases in agricultural production. Currently, control of bacterial wilt mainly relies on chemical fungicides and soil disinfection. However, long-term use can easily lead to pathogen resistance and soil residues. Therefore, developing environmentally friendly novel antimicrobial materials and preparation methods has become a key research focus in this field.

[0003] Existing related technologies have been researched in different directions: (Chinese Patent, Publication No.: CN114603153A) discloses a method for preparing bimetallic particles composed of self-assembled copper and silver nanoparticles. The method involves liquid-phase self-assembly to form copper-silver bimetallic particles, demonstrating the antibacterial properties of the bimetallic structure. The preparation route of copper-silver bimetallic particles using bovine serum albumin template combined with sodium borohydride aqueous phase reduction is relatively mature. (Chinese Patent, Publication No.: CN111296445B) discloses targeted nanoparticles for Ralstonia solanacearum, their preparation method, and applications. Targeted modification enhances the efficacy of the nanoparticles against Ralstonia solanacearum, verifying the application potential of nanomaterials in the prevention and control of Ralstonia solanacearum. (Chinese Patent, Publication No.: CN110089507B) discloses the use of melatonin, confirming that melatonin itself possesses antibacterial activity and can be applied to the prevention and treatment of bacterial infections. Existing research also indicates that melatonin can be used to modify some single-metal nanoparticles, improving the bioactivity and stability of the materials.

[0004] Although the above technologies have been studied separately, there are no reports on the preparation methods of melatonin-modified copper-silver bimetallic nanoparticles and their application in the control of Ralstonia solanacearum. The existing technologies still have the following shortcomings:

[0005] 1. Traditional methods for controlling bacterial wilt have significant shortcomings. Long-term application of chemical fungicides can easily induce drug resistance in pathogens and leave residues in soil and agricultural products, which does not meet the requirements of green agriculture development. Physical control and agricultural cultivation measures have limited control efficiency and are unable to cope with the rapid spread of pathogens during peak periods. There is also a shortage of green and efficient bacterial wilt control agents.

[0006] 2. Conventional copper-silver bimetallic nanoparticles have limitations in their application performance. The products obtained by existing preparation processes have poor aqueous dispersibility, and the particles are prone to agglomeration and sedimentation. Furthermore, the surface charge is not well-matched with the negatively charged cell membrane of Ralstonia solanacearum, resulting in a higher effective antibacterial concentration. In actual field applications, the effect is easily affected by soil environmental factors, and the stability of the effect needs to be improved.

[0007] 3. Existing nanomaterials for bacterial wilt resistance have relatively limited functions. Most nanomaterials only focus on direct antibacterial action and cannot simultaneously alleviate crop oxidative stress caused by pathogen infection. They are difficult to balance pathogen inhibition and crop stress resistance enhancement, resulting in limited overall disease control effects and failing to meet the application requirements of integrated prevention and control.

[0008] 4. The binding mechanism of melatonin and metal nanomaterials has defects. Existing applications mostly use simple physical mixing methods, which do not form a stable in-situ composite structure. Melatonin is prone to burst release, and the material has poor storage stability. The synergistic effect of the two on antibacterial and antioxidant properties cannot be fully utilized, and a dedicated composite nanomaterial system for Ralstonia solanacearum has not yet been established.

[0009] Therefore, a method for preparing melatonin copper-silver composite nanoparticles and their application against Ralstonia solanacearum are needed to solve the above problems. Summary of the Invention

[0010] The purpose of this invention is to provide a method for preparing melatonin copper-silver composite nanoparticles and their application against Ralstonia solanacearum, so as to solve the problems mentioned in the background art.

[0011] To achieve the above objectives, the present invention provides the following technical solution: a method for preparing melatonin copper-silver composite nanoparticles, comprising the following steps:

[0012] S1. Bovine serum albumin was added to sterile water at room temperature and stirred to dissolve. Copper sulfate solution was then added and mixed at room temperature to obtain the first mixed solution.

[0013] S2. Add silver nitrate solution and sterile water to the first mixed solution, stir and mix in the dark to obtain the second mixed solution;

[0014] S3. Add freshly prepared sodium borohydride solution to the second mixed solution, stir and react at room temperature in the dark to obtain copper-silver bimetallic nanoparticle precursor solution.

[0015] S4. Add freshly prepared melatonin solution to the copper-silver bimetallic nanoparticle precursor solution, stir and react at room temperature in the dark, centrifuge after the reaction is completed, and resuspend the precipitate in sterile water to obtain melatonin copper-silver composite nanoparticles.

[0016] This scheme adopts a room-temperature aqueous phase synthesis route, using bovine serum albumin as a template and sodium borohydride as a reducing agent to complete bimetallic reduction and in-situ modification of melatonin step by step. The core steps are clear and controllable, and no special high-temperature and high-pressure equipment is required. It can stably prepare composite nanoparticles with good dispersibility and bioactivity.

[0017] In a further technical solution, in step S1, the ratio of bovine serum albumin to sterile water is 0.005g~0.02g:1mL, the concentration of copper sulfate solution is 50mg / mL~200mg / mL, the addition volume is 5μL~20μL, and the stirring time at room temperature is 10min~20min.

[0018] By defining the parameter range of the first step of raw material ratio and reaction conditions, the binding density of copper ions on the protein template can be precisely controlled, ensuring uniform nucleation of particles, adapting to the preparation needs of different particle sizes and copper contents, and effectively improving the batch stability and parameter adjustability of the preparation process.

[0019] In a further technical solution, in step S2, the concentration of silver nitrate solution is 2.5 mg / mL to 10 mg / mL, the added volume is 80 µL to 320 µL, the volume of sterile water added is adjusted synchronously with the volume of silver source, and the stirring time in the dark is 10 min to 20 min.

[0020] By limiting the parameter range of silver source feeding and light-shielded reaction, the premature photolysis of silver ions due to light exposure can be reduced, the elemental composition ratio of copper-silver bimetal can be controlled, and it can be adapted to the preparation of materials with different antibacterial focuses, ensuring the compositional uniformity and structural stability of the bimetallic core.

[0021] In a further technical solution, in step S3, the concentration of sodium borohydride solution is 0.5 mg / mL to 2 mg / mL, the added volume is 5 µL to 20 µL, and the reaction time is 20 min to 40 min with stirring at room temperature in the dark.

[0022] By limiting the concentration, dosage, and reaction time range of the reducing agent, freshly prepared reducing agent can ensure reduction activity, precisely control the reduction rate and growth degree of particles, avoid excessive particle aggregation and growth, and effectively maintain the nanoscale size and uniform morphology of the material.

[0023] In a further technical solution, in step S4, the concentration of the melatonin solution is 1 mg / mL to 4 mg / mL, the added volume is 50 µL to 200 µL, and the reaction time is 20 min to 40 min with stirring at room temperature in the dark.

[0024] The feeding and reaction conditions of melatonin are limited, and the thickness and binding amount of the surface modification layer can be controlled to ensure that melatonin and the bimetallic core form a stable in-situ binding structure, which is suitable for the preparation of materials with different antioxidant and antibacterial synergistic requirements.

[0025] In a further technical solution, in step S4, the centrifugation speed is 8000rpm~15000rpm, the centrifugation time is 10min~20min, the supernatant is discarded after centrifugation, and the precipitate is resuspended in sterile water.

[0026] By defining the parameter range for post-centrifugation processing, nanoparticle products can be effectively separated and collected, while unreacted small molecule raw materials and impurities are removed, improving product purity. This allows for compatibility with different scale preparation systems and ensures the stability of subsequent application effects.

[0027] Application of melatonin copper-silver composite nanoparticles prepared by the above method in inhibiting Ralstonia solanacearum.

[0028] This study expands the application scenarios of melatonin-based composite nanomaterials in the field of agricultural pathogen control, providing a novel nanomaterial option for the green control of Ralstonia solanacearum. It can reduce the amount of chemical pesticides used and has good ecological benefits and application value.

[0029] A further technical solution is that the detection method for inhibiting Ralstonia solanacearum includes plate inhibition zone determination, minimum inhibitory concentration determination, and bacterial growth curve inhibition determination.

[0030] It defines three mainstream detection methods for antibacterial activity, covering a complete evaluation dimension of qualitative observation, quantitative determination and dynamic monitoring, which can provide standardized methodological support and data basis for material performance evaluation, quality testing and subsequent application development.

[0031] Further technical solutions include application scenarios such as soil irrigation for crop wilt control or seed soaking pretreatment for crop seedlings.

[0032] The material is defined in two typical agricultural application scenarios, providing a clear implementation path for actual field application. It can be adapted to the bacterial wilt control needs of different crops and different growth stages, effectively improving the practical value and applicability of the material.

[0033] In a further technical solution, the minimum effective concentration of the melatonin copper-silver composite nanoparticles against Ralstonia solanacearum is 6 μg / mL.

[0034] The minimum effective concentration of the material against Ralstonia solanacearum is defined, which can provide a quantitative reference for the formulation and dosage setting of the agent in practical applications, making it easier for users to accurately control the application concentration and control the cost of use while ensuring the control effect.

[0035] Compared with the prior art, the beneficial effects of the present invention are:

[0036] This invention yields composite nanomaterials with excellent dispersibility and charge compatibility: through dual regulation using bovine serum albumin template and melatonin modification, the particle morphology and surface potential are optimized, and the positive charge characteristics can enhance the electrostatic binding with pathogens, effectively reducing the effective antibacterial concentration and improving the stability of the material in complex environments.

[0037] This invention provides a material with both antibacterial and antioxidant activities: the copper-silver bimetallic component inhibits the growth and reproduction of Ralstonia solanacearum through multiple pathways, and the melatonin-modified layer can scavenge reactive oxygen free radicals, thus simultaneously achieving pathogen control and crop oxidative stress relief, improving the overall disease control effect, and expanding the functional boundaries of nano-antibacterial materials.

[0038] This invention employs an in-situ modification process to form a stable composite structure: melatonin is firmly bound to the bimetallic core, making burst release less likely, and the performance fluctuations during material storage and use are minimal; the in-situ binding structure ensures a high degree of matching between the two action sites, resulting in a synergistic effect superior to simple physical mixing, and a more significant inhibitory effect on Ralstonia solanacearum.

[0039] This invention has good industrial adaptability: the entire process is carried out at room temperature, without the need for high-temperature and high-pressure equipment, the operation steps are simple and controllable, the process parameters have a wide range of adjustable parameters, it can adapt to different scales of preparation needs, the product batch stability is good, it has the feasibility of industrial scale-up production, and it is easy to promote and apply in agricultural scenarios.

[0040] To more clearly illustrate the structural features and effects of the present invention, the present invention will be described in detail below with reference to the accompanying drawings and specific embodiments. Attached Figure Description

[0041] Figure 1 This is a schematic diagram of the overall process of the present invention;

[0042] Figure 2 The image shows the UV-Vis spectrum of the melatonin copper-silver composite nanoparticles prepared in this invention.

[0043] Figure 3 The surface Zeta potential diagram of the melatonin copper-silver composite nanoparticles prepared in this invention;

[0044] Figure 4 The image shows a transmission electron microscope image of the melatonin copper-silver composite nanoparticles prepared in this invention, where the bar in figure A corresponds to 100 nm and the bar in figure B corresponds to 20 nm.

[0045] Figure 5 The following are energy dispersive X-ray spectroscopy (EDS) images of the melatonin copper-silver composite nanoparticles prepared in this invention: Figure A is the bright-field morphology image, Figure B is the energy dispersive X-ray spectrum, Figure C is the copper elemental mapping image, Figure D is the silver elemental mapping image, and Figure E is the elemental percentage statistics table.

[0046] Figure 6 This is a graph showing the in vitro antioxidant capacity of melatonin copper-silver composite nanoparticles of different concentrations according to the present invention.

[0047] Figure 7 This is a diagram showing the inhibition zones of different treatments of Ralstonia solanacearum against Ralstonia solanacearum.

[0048] Figure 8 This is a diagram showing the minimum inhibitory concentrations of the melatonin copper-silver composite nanoparticles of the present invention against different Ralstonia solanacearum species.

[0049] Figure 9 This is a growth curve of the reaction between Ralstonia solanacearum RS556 and melatonin copper-silver composite nanoparticles of different concentrations. Detailed Implementation

[0050] The present invention will be further described below with reference to embodiments.

[0051] The following embodiments are used to illustrate the present invention, but should not be used to limit the scope of protection of the present invention. The conditions in the embodiments can be further adjusted according to specific conditions, and simple improvements to the method of the present invention under the premise of the concept of the present invention are all within the scope of protection claimed by the present invention.

[0052] Example 1

[0053] like Figure 1-9 As shown in the figure, this invention provides a method for preparing melatonin copper-silver composite nanoparticles, the specific steps of which are as follows:

[0054] (1) Preparation of the first mixed solution: At room temperature, weigh 0.01g of bovine serum albumin and add it to 1mL of sterile water. Place it on a magnetic stirrer and stir until completely dissolved. While stirring, slowly add 10μL of copper sulfate solution with a concentration of 100mg / mL. After the addition is complete, stir at room temperature for 15min to allow copper ions to fully combine with bovine serum albumin and obtain the first mixed solution.

[0055] (2) Preparation of the second mixed solution: Add 160µL of silver nitrate solution with a concentration of 5mg / mL and 660µL of sterile water to the first mixed solution to make up the total volume of the system. Stir for 15min in the dark throughout the process to make the silver ions uniformly dispersed in the system and adsorbed together with copper ions on the bovine serum albumin template to obtain the second mixed solution.

[0056] (3) Preparation of copper-silver bimetallic precursor solution: Add 10µL of freshly prepared sodium borohydride solution with a concentration of 1mg / mL to the second mixed solution above. After adding, stir the reaction at room temperature in the dark for 30min. Sodium borohydride acts as a reducing agent to reduce copper and silver ions in the system to the metallic state. Under the regulation of bovine serum albumin template, copper-silver bimetallic nanoparticle cores are formed, and copper-silver bimetallic nanoparticle precursor solution is obtained.

[0057] (4) Melatonin modification and post-treatment: Add 100µL of freshly prepared melatonin solution with a concentration of 2mg / mL to the above copper-silver bimetallic nanoparticle precursor solution, stir at room temperature in the dark for 30min, so that melatonin molecules can bind to the surface of bimetallic nanoparticles in situ through intermolecular forces, thus completing the surface modification; after the reaction, transfer the reaction solution to a centrifuge tube, centrifuge at 12000rpm for 15min, discard the supernatant after centrifugation, collect the bottom precipitate, and redissolve the precipitate in sterile water to obtain melatonin copper-silver composite nanoparticles.

[0058] (5) Physicochemical characterization: The prepared composite nanoparticles were characterized by ultraviolet-visible spectroscopy, zeta potential, transmission electron microscopy, and energy dispersive spectroscopy. The results showed that the material had a characteristic ultraviolet absorption peak at 420 nm; the zeta potential was 21.42 mV, and the surface was positively charged; the particles showed no obvious aggregation and good monodispersity; the atomic percentage of copper was 10.31%, and the atomic percentage of silver was 89.69%, confirming that structurally stable melatonin copper-silver composite nanoparticles could be successfully prepared by this process.

[0059] In this embodiment, the original parameters disclosed were used as the baseline preparation process, which fully presented the four-step preparation process and product characterization results, verifying the feasibility of the preparation method and the core structural features of the product.

[0060] Example 2

[0061] The difference between this embodiment and Example 1 is that parallel batch preparations were performed using the same process parameters to verify the batch repeatability and stability of the process. 10 μL of a 100 mg / mL copper sulfate solution was slowly added dropwise while stirring. The amounts of other raw materials, operating steps, and reaction parameters remained consistent with Example 1, resulting in parallel batches of melatonin copper-silver composite nanoparticles.

[0062] In this embodiment, the feeding method and process parameters for parallel batches were completely consistent with those of the baseline embodiment. The atomic percentage, particle morphology, and dispersibility of copper in the product were not significantly different from those of Example 1. Energy dispersive spectroscopy (EDS) characterization verified that the atomic percentage of copper was within a stable range, with batch-to-batch deviations of less than 3%. Parallel antibacterial tests showed that the product's antibacterial activity against Ralstonia solanacearum was comparable to that of Example 1, with inhibition zone diameter fluctuations of less than 5%, and good monodispersity. This embodiment verifies that the preparation process has good batch repeatability, stable product performance, and is feasible for scale-up preparation.

[0063] Example 3

[0064] The difference between this embodiment and Example 2 is that the amount of bovine serum albumin added in step S1 is adjusted to change the template concentration. The amount of bovine serum albumin added is adjusted to 0.015g, while the corresponding sterile water volume remains 1mL. The remaining operation steps and reaction parameters are consistent with those in Example 2, resulting in the preparation of melatonin copper-silver composite nanoparticles with increased template concentration.

[0065] In this embodiment, the increased bovine serum albumin template concentration led to an increase in nucleation sites and enhanced steric hindrance. Transmission electron microscopy (TEM) characterization confirmed that the particles maintained good monodispersity with no significant aggregation; the particle size was slightly reduced and more uniformly distributed; the zeta potential remained within the positive charge range. This embodiment demonstrates that adjusting the template concentration parameter within the protected range can further optimize particle dispersibility and size uniformity, and that the preparation process exhibits good tolerance.

[0066] Example 4

[0067] The difference between this embodiment and Example 3 is that the reaction time of sodium borohydride in step S3 is adjusted to change the reduction reaction process. The reaction time at room temperature with stirring is adjusted to 35 minutes, while the amounts of other raw materials and operating steps remain the same as in Example 3, thus preparing melatonin copper-silver composite nanoparticles with adjusted reduction time.

[0068] In this embodiment, the reduction reaction time is extended, resulting in more complete reduction of metal ions and increased particle growth time. UV characterization verified that the characteristic absorption peak position did not shift significantly, indicating no fundamental change in the bimetallic structure; the particle size increased slightly but remained at the nanoscale, and the dispersibility remained stable. This embodiment verifies that structurally complete composite nanoparticles can be obtained by adjusting the reduction reaction time within the protected range, demonstrating good process adaptability.

[0069] Example 5

[0070] The difference between this embodiment and Example 4 is that the volume of the melatonin solution added in step S4 is adjusted to change the thickness of the surface modification layer. The volume of the melatonin solution added is adjusted to 150 µL, while the remaining operation steps and reaction parameters are consistent with those in Example 4, thus preparing composite nanoparticles with increased melatonin modification.

[0071] In this embodiment, the increased amount of melatonin resulted in a corresponding increase in the thickness of the modification layer on the particle surface. Zeta potential characterization confirmed that the surface positive charge characteristics remained stable; preliminary antioxidant tests showed that the material's free radical... The improvement is slight, consistent with the trend of increasing melatonin modification levels. This embodiment verifies that adjusting the melatonin dosage parameters within the protected range can regulate the antioxidant properties of the material, adapting it to different application requirements.

[0072] Example 6

[0073] The difference between this embodiment and Embodiment 5 is that the post-centrifugation parameters in step S4 are adjusted to change the product collection conditions. The centrifugation speed is adjusted to 10,000 rpm and the centrifugation time is adjusted to 18 min, while the remaining operation steps are consistent with Embodiment 5, thus preparing composite nanoparticles under different post-treatment conditions.

[0074] In this embodiment, reducing the centrifugation speed and extending the centrifugation time still effectively collected the nanoparticle products in the system, and the product recovery rate remained within a reasonable range. Performance verification showed that the purity, dispersibility, and antibacterial activity of the material were not significantly different from the baseline group, and the core performance remained stable. This embodiment verifies that adjusting the centrifugation parameters within the protected range does not affect the core performance of the final product and is adaptable to preparation equipment of different scales.

[0075] Example 7

[0076] like Figure 6 As shown, the difference between this embodiment and Example 6 is that the in vitro antioxidant activity of the prepared melatonin copper-silver composite nanoparticles was measured to verify the functional characteristics of the product. Using the sample prepared in Example 6 as the test object, the antioxidant capacity of the material was determined by DPPH free radical scavenging experiments and ABTS free radical scavenging experiments, respectively. The specific operations are as follows:

[0077] (1) Determination of DPPH free radical scavenging activity: Weigh 0.001 g DPPH, add 20 mL anhydrous ethanol, mix well, and store in the dark for later use; dilute the composite nanoparticles into different concentration gradients for later use. Add 100 μL of composite nanoparticles of different concentrations to a sterile 96-well plate, and then add 100 μL of DPPH solution as the sample group; use 100 μL of sterile water instead of the sample as the blank control group; mix 100 μL of sterile water with 100 μL of DPPH solution as the blank control group. After reacting at room temperature in the dark for 30 min, measure the absorbance at 517 nm and calculate the scavenging rate.

[0078] (2) Determination of ABTS free radical scavenging activity: 0.0132 g of potassium persulfate was dissolved in 2 mL of anhydrous ethanol to obtain solution A, and 0.0076 g of ABTS was dissolved in 2 mL of anhydrous ethanol to obtain solution B. The solutions were mixed in equal volumes and allowed to stand at room temperature in the dark for 12 h to obtain the ABTS stock solution. The stock solution was diluted with anhydrous ethanol until the absorbance at 734 nm was less than 0.7. The composite nanoparticles were diluted into different concentration gradients for later use. 100 μL of sample and 100 μL of ABTS working solution were added to a 96-well plate as the sample group; anhydrous ethanol was used as the sample blank control group; and anhydrous ethanol and ABTS working solution were mixed as the blank control group. After reacting at room temperature in the dark for 30 min, the absorbance at 734 nm was measured and the scavenging rate was calculated.

[0079] This experiment uses a unified formula to calculate free radicals. The formula is as follows:

[0080]

[0081] In the formula:

[0082] The absorbance of the blank control group represents the initial total amount of free radicals, which is obtained by measuring the pure free radical working solution system at the corresponding wavelength. The initial absorbance of the ABTS system must be less than 0.7 to ensure detection linearity.

[0083] The absorbance of the sample group represents the absorbance corresponding to the remaining free radicals after the reaction, and is obtained from the mixture of the sample and the free radical working solution.

[0084] The absorbance is the absorbance of the blank control group of the sample, representing the background absorbance of the sample itself. It is used to subtract the interference of sample color on the detection results and is obtained by measuring the mixture of the sample and the corresponding solvent.

[0085] The formula control logic is to eliminate the color interference of the sample itself by background subtraction, and calculate the free radical scavenging ratio based on the blank group. The result range is 0~100%, and the higher the value, the stronger the antioxidant capacity.

[0086] In this embodiment, the test results showed that when the material concentration was 30 μg / mL, the DPPH free radical scavenging rate was 46.47 ± 1.82%, and the ABTS free radical scavenging rate was 48.74 ± 1.23%, confirming that the material obtained by this preparation method possesses good in vitro antioxidant activity. This embodiment fully verifies the antioxidant function of the product and provides data support for the synergistic application of dual functions.

[0087] Example 8

[0088] like Figure 7-9 As shown, the difference between this embodiment and Example 7 is that the antibacterial activity of the prepared melatonin copper-silver composite nanoparticles against Ralstonia solanacearum was determined to verify the application effect of the material, including three parts: inhibition zone experiment, minimum inhibitory concentration experiment, and growth curve experiment.

[0089] (1) Inhibition zone experiment: Three strains of Ralstonia solanacearum RS212, RS550 and RS556 were selected. After being cultured to the logarithmic growth phase, the OD600 of the bacterial solution was adjusted to 0.1 and spread on solid culture medium. Sterile filter paper was placed and sterile water, melatonin solution, unmodified copper-silver nanoparticles and melatonin copper-silver composite nanoparticles were added respectively. After culturing for 24 hours, the diameter of the inhibition zone was measured.

[0090] (2) Minimum inhibitory concentration experiment: Adjust the bacterial concentration to 1.0×10^8 CFU / mL, set different concentration gradients of materials and bacterial solutions in a 96-well plate for co-culture, incubate at 37℃ for 24h, add 2,3,5-triphenyltetrazolium chloride for color development, and the lowest concentration with no color change is the minimum inhibitory concentration.

[0091] (3) Growth curve experiment: Using RS556 strain as the object, the OD600 of the bacterial solution was adjusted to 0.6, and it was co-cultured with materials of different concentrations. The OD600 value was measured every 2 hours, and the growth curve was plotted continuously for 24 hours.

[0092] In this embodiment, the inhibition zone experiment results showed that sterile water and pure melatonin had no significant antibacterial effect. The inhibition zone diameters of the composite nanoparticles prepared by this method against the three strains of bacteria were all larger than those of the unmodified copper-silver nanoparticles. The inhibition zone diameters against RS212, RS550, and RS556 were 14.93±0.15 mm, 14.27±0.26 mm, and 11.66±0.8 mm, respectively, confirming the synergistic antibacterial effect of melatonin and bimetals. The minimum inhibitory concentration (MIC) experiment showed that the material had a MIC of 6 μg / mL against the three strains of bacteria. The growth curve experiment showed that bacterial growth was almost completely inhibited at a concentration of 6 μg / mL, and bacterial growth was significantly delayed at a concentration of 3 μg / mL. This embodiment fully verified the high-efficiency antibacterial activity of the material against multiple strains of Ralstonia solanacearum.

[0093] Working principle and usage process of this invention:

[0094] The core working principle of this invention is a triple synergistic mechanism: the first is the antibacterial synergy of copper and silver bimetals, where the two metal ions can act on the bacterial cell membrane, intracellular enzyme system and genetic material respectively, inhibiting bacterial growth and reproduction through multiple pathways, and the effect is better than that of single metal nanoparticles; the second is the antibacterial synergy of melatonin and bimetals, where positively charged surface-enhanced particles adsorb and bind to bacteria, and the antibacterial activity of melatonin itself forms a superposition effect with the metal ions, improving the antibacterial efficiency; the third is the functional synergy of antibacterial and antioxidant, which removes reactive oxygen species in the environment while inhibiting pathogens, improves the stability of the action system, and helps crops alleviate oxidative stress caused by diseases.

[0095] The typical usage process of this material includes two scenarios:

[0096] Scenario 1: Control of bacterial wilt by root irrigation in crop soil. The melatonin copper-silver composite nanoparticles prepared by this method are diluted to the working concentration and applied to the roots of crops during the seedling stage or early stage of disease. The material enters the rhizosphere soil with the water and accumulates on the surface of Ralstonia solanacearum through positive charge adsorption, inhibiting the growth and infection of the pathogen. At the same time, the melatonin component can be absorbed by the crop roots, alleviating root oxidative damage caused by the disease.

[0097] Scenario 2: Crop seedling pretreatment by soaking. The composite nanoparticles prepared by this method are diluted to a suitable concentration of working solution. Crop seeds are soaked in the working solution for a certain period of time before sowing. The material can form an antibacterial protective layer on the seed surface, inhibiting the presence of Ralstonia solanacearum in the seeds and reducing the probability of disease in the seedling stage. At the same time, melatonin can promote seed germination and root development to a certain extent, and improve the stress resistance of seedlings.

[0098] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.

Claims

1. A method for preparing melatonin copper-silver composite nanoparticles, characterized in that, Includes the following steps: S1. Bovine serum albumin was added to sterile water at room temperature and stirred to dissolve. Copper sulfate solution was then added and mixed at room temperature to obtain the first mixed solution. S2. Add silver nitrate solution and sterile water to the first mixed solution, stir and mix in the dark to obtain the second mixed solution; S3. Add freshly prepared sodium borohydride solution to the second mixed solution, stir and react at room temperature in the dark to obtain copper-silver bimetallic nanoparticle precursor solution. S4. Add freshly prepared melatonin solution to the copper-silver bimetallic nanoparticle precursor solution, stir and react at room temperature in the dark, centrifuge after the reaction is completed, and resuspend the precipitate in sterile water to obtain melatonin copper-silver composite nanoparticles.

2. The method for preparing melatonin copper-silver composite nanoparticles according to claim 1, characterized in that, In step S1, the ratio of bovine serum albumin to sterile water is 0.005g~0.02g:1mL, the concentration of copper sulfate solution is 50mg / mL~200mg / mL, the addition volume is 5μL~20μL, and the stirring time at room temperature is 10min~20min.

3. The method for preparing melatonin copper-silver composite nanoparticles according to claim 1, characterized in that, In step S2, the concentration of silver nitrate solution is 2.5 mg / mL to 10 mg / mL, the added volume is 80 µL to 320 µL, the volume of sterile water added is adjusted synchronously with the volume of silver source, and the stirring time in the dark is 10 min to 20 min.

4. The method for preparing melatonin copper-silver composite nanoparticles according to claim 1, characterized in that, In step S3, the concentration of sodium borohydride solution is 0.5 mg / mL to 2 mg / mL, the added volume is 5 µL to 20 µL, and the reaction time is 20 min to 40 min with stirring at room temperature in the dark.

5. The method for preparing melatonin copper-silver composite nanoparticles according to claim 1, characterized in that, In step S4, the melatonin solution concentration is 1 mg / mL to 4 mg / mL, the added volume is 50 µL to 200 µL, and the reaction time is 20 min to 40 min with stirring at room temperature in the dark.

6. The method for preparing melatonin copper-silver composite nanoparticles according to claim 1, characterized in that, In step S4, the centrifugation speed is 8000rpm~15000rpm, the centrifugation time is 10min~20min, the supernatant is discarded after centrifugation, and the precipitate is resuspended in sterile water.

7. The application of melatonin copper-silver composite nanoparticles prepared by the preparation method according to any one of claims 1-6 in inhibiting Ralstonia solanacearum.

8. The application according to claim 7, characterized in that, The detection methods for inhibiting Ralstonia solanacearum include plate inhibition zone determination, minimum inhibitory concentration determination, and bacterial growth curve inhibition determination.

9. The application according to claim 7, characterized in that, The application scenarios include soil irrigation for crop control of bacterial wilt or seed soaking pretreatment of crop seedlings.

10. The application according to claim 7, characterized in that, The minimum effective concentration of the melatonin copper-silver composite nanoparticles against Ralstonia solanacearum is 6 μg / mL.

Citation Information

Patent Citations

  • Pest situation forecasting equipment and control method based on pest situation forecasting equipment

    CN110089507A

  • Ralstonia solanacearum targeted nanomedicine, its preparation method and application

    CN111296445B

  • Preparation method of bimetallic particles formed by self-assembly of nano-copper and nano-silver

    CN114603153A